{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:XIQJY6HURUGGM6CODEB6XLIVCF","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9","cross_cats_sorted":["stat.AP","stat.ME"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49"},"schema_version":"1.0","source":{"id":"1907.00161","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"arxiv_version","alias_value":"1907.00161v1","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"pith_short_12","alias_value":"XIQJY6HURUGG","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_16","alias_value":"XIQJY6HURUGGM6CO","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_8","alias_value":"XIQJY6HU","created_at":"2026-05-18T12:33:33Z"}],"graph_snapshots":[{"event_id":"sha256:a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d","target":"graph","created_at":"2026-05-17T23:41:57Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"This manuscript introduces an \\proglang{R} package called \\pkg{trialr} that implements a collection of clinical trial methods in \\proglang{Stan} and \\proglang{R}. In this article, we explore three methods in detail. The first is the continual reassessment method for conducting phase I dose-finding trials that seek a maximum tolerable dose. The second is EffTox, a dose-finding design that scrutinises doses by joint efficacy and toxicity outcomes. The third is the augmented binary method for modelling the probability of treatment success in phase II oncology trials with reference to repeated mea","authors_text":"Kristian Brock","cross_cats":["stat.AP","stat.ME"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title":"trialr: Bayesian Clinical Trial Designs in R and Stan"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1907.00161","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49","target":"record","created_at":"2026-05-17T23:41:57Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9","cross_cats_sorted":["stat.AP","stat.ME"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49"},"schema_version":"1.0","source":{"id":"1907.00161","kind":"arxiv","version":1}},"canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","first_computed_at":"2026-05-17T23:41:57.294420Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:41:57.294420Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"PPPX6ceg1YcZDGhw08pQqtWgxNWL/uPl47gfpEhzAoZ1KuwNmHEWqGr85VX9H2SZE9St/F05escW1nS8ZjW+AA==","signature_status":"signed_v1","signed_at":"2026-05-17T23:41:57.294986Z","signed_message":"canonical_sha256_bytes"},"source_id":"1907.00161","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49","sha256:a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d"],"state_sha256":"9380dda0bbdf93c10b007681d723f0ca3f9885c1a7f5f96c079e52784fb7028b"}